Diligence memo · auto-generated · as of July 2, 2026
Active Genomes Expressed Diagnostics Corp
Active Genomes Expressed Diagnostics Corp looks fair against its niche peers and is dormant on financing cadence.
Businessfiled
Active Genomes Expressed Diagnostics Corp operates in Medical Devices, based in WASHINGTON.
Sub-sector tags: medical-devices.
No verified homepage on file yet — operating evidence is limited to the public record.
Capital & rounds (filed)filed
Active Genomes Expressed Diagnostics Corp has raised $250K in disclosed capital across 1 recorded round, aggregated from public filings. Its latest round is modeled as Pre-Seed (a round under $1.0M).
Largest single filing: $250K on 2022-12-29.
Most recent recorded round closed around 2022-12-29.
Valuation (modeled)modeled
Provath models Active Genomes Expressed Diagnostics Corp at approximately $2.4M (range $150K–$13M). This is an algorithmic estimate from round sizes and same-niche peers — not a quoted or reported figure.
Read: Fair. Modeled value is 0.87× the median modeled value of Pre-Seed Medical Devices companies in 2022–2024 (29 peers) — value vs value, same stage and era. Within the normal band (87% of peer median) for its niche.
Financing rhythm & timingmixed
Last raise 3.5 yr ago; this sector typically re-raises about every 16 months.
Only one round on record and long silent — often defunct, acquired, or gone quiet.
Comparablesmixed
Capital scale ranks ahead of 20% of Medical Devices peers (233 compared).
Modeled value ranks above 27% of those peers.
Closest niche peers: Turbett Surgical, Inc., Owensboro Ambulatory Surgical Facility Ltd, Seashore Surgical Institute, L.L.C., Hera Diagnostics Corp, Hawkeye Surgical Lighting.
Peoplefiled
1 named person on file across officers, directors and signatories.
Risks & flagsmixed
Financing has been silent well beyond sector cadence — possibly defunct, acquired, or paused.
No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.